Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.2382
-0.0068 (-2.78%)
May 9, 2025, 11:42 AM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $258.19 thousand as of May 9, 2025. Its market cap has decreased by -93.05% in one year.
Market Cap
258.19K
Enterprise Value
-1.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 258.19K, a decrease of -99.20%. That is a compound annual growth rate of -68.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 258.19K | -86.09% |
Dec 31, 2024 | 1.86M | -50.48% |
Dec 29, 2023 | 3.75M | -48.56% |
Dec 30, 2022 | 7.29M | -81.86% |
Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.62B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 729.60M |
Tian'an Technology Group | 568.98M |
Glass House Brands | 484.30M |
Elite Pharmaceuticals | 448.25M |
CytoDyn | 401.33M |
Northwest Biotherapeutics | 390.49M |